Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TJO-087 in dry eye disease
NCT07810972Phase 2Active, not recruiting
- Sponsor
- Taejoon Pharmaceutical Co., Ltd.
- Start
- Apr 2026
- Primary completion
- Oct 2026
- Countries
- 1
01
Overview
A Phase 2 trial of TJO-087 in dry eye syndrome (DED), sponsored by Taejoon Pharmaceutical Co., Ltd.. Started Apr 2026; status: active, not recruiting.
02
Drugs
TJO-087
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT07810972.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07810972.